AcquisitionsJul 20, 2026, 05:01 PM
Jin Medical Shareholders Approve Tongsheng Acquisition, Major Share Changes
AI Summary
Jin Medical International Ltd. shareholders approved several significant proposals, including the acquisition of Beijing Tongsheng Technology Co., Ltd. via a VIE structure, involving the issuance of 64,186,456 Class A Ordinary Shares. Additionally, shareholders approved increasing Class B Ordinary Share voting rights from 30 to 800 votes, a repurchase of 3,769,057 Class A shares, and a concurrent issuance of 3,769,057 Class B shares to Jolly Harmony, an entity owned by the CEO. The company also increased its authorized share capital and approved a financial advisor engagement.
Key Highlights
- Shareholders approved the acquisition of Beijing Tongsheng Technology Co., Ltd.
- 64,186,456 Class A Ordinary Shares to be issued for the Tongsheng acquisition.
- Class B Ordinary Share voting rights increased from 30 to 800 votes per share.
- Company to repurchase 3,769,057 Class A Ordinary Shares from CEO's entity.
- Company to issue 3,769,057 Class B Ordinary Shares to CEO's entity.
- Authorized share capital increased to US$15,005,000.
- Approved engagement of Goldeenridge Ventures Ltd. as financial advisor.
Price Impact
More from ZJYL